AMORPHOUS FORM OF A 3-PYRROLE SUBSTITUTED 2-INDOLINONE MALATE SALT

摘要

Disclosed are new forms of the anticancer agent sunitinib of formula (I), and pharmaceutically acceptable salts thereof, including amorphous form sunitinib malate and sunitinib malate Form III. Also disclosed is a process for preparing and pharmaceutical compositions comprising amorphous form sunitinib malate.